| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INSP | Common Stock | Sale | -$122K | -490 | -3.25% | $249.08 | 14.6K | Feb 6, 2023 | Direct | F1, F2 |
| transaction | INSP | Common Stock | Sale | -$425K | -1.7K | -11.64% | $249.91 | 12.9K | Feb 6, 2023 | Direct | F1, F3 |
| transaction | INSP | Common Stock | Sale | -$238K | -949 | -7.36% | $250.73 | 12K | Feb 6, 2023 | Direct | F1, F4 |
| transaction | INSP | Common Stock | Sale | -$90.9K | -361 | -3.02% | $251.72 | 11.6K | Feb 6, 2023 | Direct | F1, F5 |
| transaction | INSP | Common Stock | Sale | -$249K | -940 | -8.11% | $265.00 | 10.7K | Feb 8, 2023 | Direct | F1 |
| transaction | INSP | Common Stock | Sale | -$421K | -1.56K | -14.65% | $270.00 | 9.09K | Feb 8, 2023 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $248.34 to $249.28, inclusive. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.41 to $250.40, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.42 to $251.34, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $251.42 to $252.06, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |